Radioligand therapy
@radioligand
Followers
1K
Following
119
Media
490
Statuses
1K
We aim to highlight radioligand therapy as a component of cancer care. The project is supported by @adacap_news.
Joined November 2019
Countries planning to adopt radioligand therapy need to build readiness for its implementation, to ensure equitable access with increased demand. To support ongoing efforts, we've published a series of four national calls to action.
healthpolicypartnership.com
Radioligand therapy is a targeted treatment with huge potential to improve cancer care around the world; HPP collaborated with experts to identify key barriers to implementing radioligand therapy and...
0
0
0
Building on our extensive work on radioligand therapy and #HealthSystemReadiness, we’ve developed a set of key performance indicators that can serve as targets for countries looking to integrate #RadioligandTherapy.
healthpolicypartnership.com
Key performance indicators provide concrete targets that countries can work towards to ensure they are ready to adopt innovative treatments.
0
0
0
We have published a new post on the #RadioligandTherapy Readiness Hub looking at how @BartsHospital set up a Gallium-68 service. Read about how using a systems approach ensured successful integration of radioisotopes into care: https://t.co/tjnNEionOb
healthsystemreadiness.com
Using a charity grant, St Bartholomew’s Hospital (Barts) in London set up a Gallium-68 service.
0
0
0
Our Radioligand Therapy Readiness Hub showcases examples of how different countries have implemented guidelines and care pathways to ensure their health system is ready to deliver #RadioligandTherapy to those who will benefit from it most. Read more:
healthsystemreadiness.com
Using a charity grant, St Bartholomew’s Hospital (Barts) in London set up a Gallium-68 service.
0
0
3
The Radioligand Therapy Readiness Assessment Framework has been adapted and applied in the Republic of Korea! Availability of #radioligand therapy is limited in the country, with many people having to travel abroad to seek treatment. Find out more:
healthsystemreadiness.com
In July 2023, GR Korea hosted a webinar with support from HPP, where experts discussed the future of radioligand therapy in the Republic of Korea.
0
1
5
Are you looking to develop a radioligand therapy service, but concerned about the time it will take? Learn from practices in New Zealand which allowed the development of a service in just 8 weeks:
healthsystemreadiness.com
In the midst of the COVID-19 pandemic, New Zealand’s developed the country’s first radioligand therapy service in just eight weeks.
0
0
2
In just 8 weeks, organisations across the health sector in New Zealand collaborated to establish the country’s first #RadioligandTherapyservice. It has since been able to expand in line with demand. Learn more via our Radioligand Therapy Readiness Hub:
healthsystemreadiness.com
In the midst of the COVID-19 pandemic, New Zealand’s developed the country’s first radioligand therapy service in just eight weeks.
0
0
1
Our newest post highlights how a #RadioligandTherapy service was established in New Zealand following COVID-19 border closures. The service continues to grow to meet demand, so more people can access the treatment they need. Read here:
healthsystemreadiness.com
In the midst of the COVID-19 pandemic, New Zealand’s developed the country’s first radioligand therapy service in just eight weeks.
0
0
0
Our Radioligand Therapy Readiness Hub showcases examples of how different countries have improved the integration of #RadioligandTherapy into care.
1
0
1
The @ASTRO_org framework is being used to set up new clinics and centres for #RadioligandTherapy in the US. Find out more about this framework and how to apply it on our new Radioligand Therapy Readiness Hub:
healthsystemreadiness.com
ASTRO has developed a framework for radioligand therapy patient-centred care pathways which outlines what is needed to ensure safe, high-quality care for people with cancer.
0
0
2
Want to learn more about patient advocacy and the key role it plays in getting innovative therapies such as #RadioligandTherapy implemented? Read Mark McDonnell's insight post here:
healthsystemreadiness.com
Mark McDonnell is Chairperson of the NET Patient Network in Ireland and President of the International Neuroendocrine Cancer Alliance (INCA).
0
0
1
0
0
0
The equitable distribution of medical equipment can help health systems become ready for #RadioligandTherapy. Learn how the intersection of @EU_Commission funding, consultations and advocacy helped to increase the number of #PETScanners across Spain 👉
healthsystemreadiness.com
Using European Commission funding, the Spanish government has increased the number of PET scanners across Spain to improve the resilience and sustainability of health systems following the COVID-19...
2
3
9
Did you know Tweet that the first radioiodine treatment was administered in 1941? Take a look back over the years to see how #Radiopharmaceuticals have been adapted for use in #Cancer treatment 👉 https://t.co/E0Aq7hXaxR
healthsystemreadiness.com
Major advances in radioligand therapy and cancer care
1
3
7
How does the systematic collection and presentation of data change policy? Discover how medical societies in Spain helped to increase the number of #PETScanners across the country 👉 https://t.co/gXT6CSyR5f
healthsystemreadiness.com
Using European Commission funding, the Spanish government has increased the number of PET scanners across Spain to improve the resilience and sustainability of health systems following the COVID-19...
0
0
1
Given the government’s increased interest in nuclear medicine, now is the time to hold discussions on #RadioligandTherapy in Australia. Following a roundtable event, @NECancerAus is continuing discussions to keep up momentum in the country. Learn more:
healthsystemreadiness.com
NeuroEndocrine Cancer Australia brought together a multi-sectoral group of experts to discuss the future of precision oncology in nuclear medicine, including radioligand therapy.
0
0
3
The @officialEANM, @SNM_MI and @iaeaorg have come together to create an international guide on how to set up a theranostics centre in preparation for the expected increased demand for #RadioligandTherapy. Read more:
healthsystemreadiness.com
The European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging and the International Atomic Energy Agency have created a joint guide to help people looking to...
0
3
7
What is our vision of readiness for #RadioligandTherapy? Assessing current integration and readiness for RLT will help health systems and governments plan for its effective use. Read more:
healthsystemreadiness.com
Assessing current integration and readiness for radioligand therapy will help us plan for its effective use.
0
0
0
If you're diagnosed with 10th most prevalent cancer in England, wouldn't you expect a formal NHS care pathway? We went to Parliament to campaign for this - please RT to support us @HNYCancer @EOE_cancer @nclcancer @HNYCancer
neuroendocrinecancer.org.uk
Neuroendocrine cancers, also known as neuroendocrine neoplasms (NENs), are a diverse group of cancers that have been increasing in incidence and prevalence in England, as well as across the UK and...
0
8
13
Using consistent terminology is important for increasing awareness & understanding of innovative therapies like #RadioligandTherapy, and makes it easier to share knowledge. Learn more:
healthsystemreadiness.com
Inconsistent use of terminology presents challenges to building awareness of radioligand therapy and appropriately integrating it into care.
0
0
0